jcm-logo

Journal Browser

Journal Browser

Corneal Surgery: From Innovation to Clinical Praxis

A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Ophthalmology".

Deadline for manuscript submissions: closed (30 June 2023) | Viewed by 18425

Special Issue Editor


E-Mail Website
Guest Editor
1. Hoopes Vision Research Center, Draper, UT 84020 USA
2. John Moran Eye Center, University of Utah School of Medicine, Salt Lake City, UT 84112, USA
3. Utah Lions Eye Bank, Murray, UT 84107, USA
Interests: cornea and external disease; refractive surgery; cataract; new IOLs; keratoconus; new corneal transplant procedures and instruments
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

It is a pleasure to announce the coming Special Issue of Journal of Clinical Medicine on “Corneal Surgery: From Innovation to Clinical Praxis.” The recent advances in corneal surgery are genuinely astounding, ranging from novel biomaterials and synthetic materials to advanced laser platforms and ophthalmic surgeons’ innovative surgical techniques. The different subtypes of allogeneic corneal transplants show the ever-increasing use of a single donor cornea for multiple procedures. The discovery of new biomaterials and the generation of tissues from well-known biologic components have contributed to newer medical and surgical management of corneal diseases. The improvements in laser platforms and their algorithms have led to more accurate and precise surgeries. The harnessing of UV light and other energy forms in new machines has led to safer and better outcomes for some progressive corneal diseases.

While some innovations will fail in the clinical setting, there will be successes, and there will always be room for improvement in the preventive or curative aspects of clinical management. We invite cornea specialists, residents, general ophthalmologists, optometrists, clinical scientists in vision research, and those engaged in the biocompatible materials sciences to contribute articles to this Special Issue. We welcome retrospective and prospective studies, case series, and case reports of relatively novel corneal surgeries and their outcomes.

The quest to maintain and improve eye health as well as prevent eye disease is the eye professional’s goal. Let us take the time to contribute to the understanding of innovative corneal biomaterials, platforms, and procedures for the benefit of our patients, the general public, medical practitioners, and eye health providers.

Prof. Dr. Majid Moshirfar
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • corneal transplantation
  • endothelial keratoplasty
  • DALK
  • bowman layer transplantation
  • DMEK
  • corneal inlay
  • corneal onlay
  • allogeneic corneal transplants
  • corneal cross-linking
  • femtosecond laser
  • excimer laser

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Research

Jump to: Review, Other

14 pages, 1683 KiB  
Article
Interleukin 12 in the Acute Phase of the Immune Response after Excimer Laser Treatment
by Mirko Resan, Zeljka Cvejic, Igor Pancevski, Gabriele Thumann, Martina Kropp, Ivo Guber, Dragana Ristic, Danilo Vojvodic and Bojan Pajic
J. Clin. Med. 2023, 12(13), 4472; https://doi.org/10.3390/jcm12134472 - 4 Jul 2023
Cited by 1 | Viewed by 1181
Abstract
Background and objectives: The aim of the research was to investigate the differences in the concentrations of IL-12, IL-4, IL-10, and IFN-γ in tears after LASIK and PRK procedures. Materials and methods: The study included 68 myopic eyes up to −3.0 D refractive [...] Read more.
Background and objectives: The aim of the research was to investigate the differences in the concentrations of IL-12, IL-4, IL-10, and IFN-γ in tears after LASIK and PRK procedures. Materials and methods: The study included 68 myopic eyes up to −3.0 D refractive spherical equivalent, divided into two groups: Group 1 LASIK (n = 31) and Group 2 PRK (n = 37). Three tear samples were taken from each eye: immediately before the procedure (t0), 1 h after the procedure (t1), and 24 h after the procedure (t2). The concentrations of IL-12p70, IL-4, IL-10, and IFN-γ in the tear samples were determined by flow cytometry. Participants were not taking anti-inflammatory therapy 24 h after the procedure. Results: IL-4 levels 1 h after treatment did not differ between LASIK and PRK (p = 0.990), while 24 h after PRK there was a significant decrease in IL-4 levels (p < 0.05), but not after LASIK (p = 0.476). In both the LASIK (p < 0.05) and PRK (p < 0.05) groups, there is an increase in IL-10 concentrations 1 h after treatment, which persists 24 h after LASIK (p < 0.05) but not after PRK (p = 0.081). There is an increase in IL-12p70 concentration 1 h after treatment in both the LASIK (p < 0.001) and PRK groups (p < 0.001). There is also an increase in IL-12p70 concentration 24 h after PRK (p < 0.005), but not after LASIK (p = 0.775). Conclusions: IL-4 concentration shows a significantly higher value in the LASIK group than in the PRK group after 24 h. IL-10 and IL-12p70 levels increase one hour after surgery in both groups. After 24 h, the IL-10 levels remain elevated in the LASIK group, and the IL-12p70 levels remain elevated in the PRK group. Thus, LASIK and PRK procedures show different inflammatory dynamics. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

9 pages, 1274 KiB  
Article
Characteristics of Grape Shelf Eye Injuries at Vineyards in Japan
by Wataru Kikushima, Yoichi Sakurada and Kenji Kashiwagi
J. Clin. Med. 2022, 11(23), 7079; https://doi.org/10.3390/jcm11237079 - 29 Nov 2022
Viewed by 1371
Abstract
We aimed to investigate the characteristics and visual outcomes of farm work-associated eye injuries at vineyards. We retrospectively reviewed medical charts of patients with farm work-associated eye injuries. The eyes were divided into two groups according to the type of farming that contributed [...] Read more.
We aimed to investigate the characteristics and visual outcomes of farm work-associated eye injuries at vineyards. We retrospectively reviewed medical charts of patients with farm work-associated eye injuries. The eyes were divided into two groups according to the type of farming that contributed to the eye injury: the vineyard and other farming groups. Injury types, surgical procedures, and changes in visual acuity were statistically evaluated. After initial treatment, patients were followed up at different periods. We examined 30 eyes, including 14 eye injuries in the vineyard group and 16 eye injuries in the other farming group. The mean age of the patients was 58.8 ± 16.7 years, and 83.3% were male. None of the patients wore any safety eyewear at the time of injury. After initial treatment, the mean best-corrected visual acuity significantly improved from 0.83 ± 0.94 at baseline to 0.30 ± 0.57 at the final follow-up (p = 5.8 × 10−4). Eye injuries in the vineyard group were mostly caused by the penetration of wires of grape shelves and were frequent from winter to spring. We concluded that farm work-associated eye injuries at vineyards have characteristic properties compared with those during other farm work. The use of safety eyewear is strongly recommended to prevent eye injuries during farm work. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

11 pages, 2081 KiB  
Article
Comparison of Corneal Higher-Order Aberrations Following Topography-Guided LASIK and SMILE for Myopic Correction: A Propensity Score Matching Analysis
by Eun Min Kang, Ik Hee Ryu, In Sik Lee, Jin Kuk Kim, Sun Woong Kim and Yong Woo Ji
J. Clin. Med. 2022, 11(20), 6171; https://doi.org/10.3390/jcm11206171 - 19 Oct 2022
Cited by 8 | Viewed by 2748
Abstract
Ocular aberrations, particularly corneal higher-order aberrations (HOAs), which impair visual quality, should be minimized or corrected during any laser vision correction. We compared changes in visual outcomes, including HOAs, in patients who underwent Topography-Guided laser-assisted in situ keratomileusis (TG-LASIK) or small-incision lenticule extraction [...] Read more.
Ocular aberrations, particularly corneal higher-order aberrations (HOAs), which impair visual quality, should be minimized or corrected during any laser vision correction. We compared changes in visual outcomes, including HOAs, in patients who underwent Topography-Guided laser-assisted in situ keratomileusis (TG-LASIK) or small-incision lenticule extraction (SMILE) after propensity score matching (PSM) to reduce selection bias. Of 2749 patients who underwent SMILE or TG-LASIK for myopia, 152 eyes underwent complete ophthalmic examination preoperatively and over six months postoperatively. Visual outcomes were comparatively analyzed after PSM. As a result, 45 eyes were included in each group after PSM. There was a comparable improvement in visual acuity (VA) and refractive parameters postoperatively, with no difference between the two PSM-groups. However, 6.6% in the SMILE PSM-group lost two or more lines of Snellen VA at the six-month follow-up, while none in the TG-LASIK PSM-group did. Specifically, the SMILE PSM-group showed a significant increase in corneal HOAs, including spherical aberration, coma, and total HOAs (0.0736 ± 0.162 μm; 0.181 ± 0.233 μm; and 0.151 ± 0.178 μm, respectively), whereas TG-LASIK PSM-group did not. Furthermore, SMILE PSM-group had greater postoperative corneal HOAs than those in TG-LASIK PSM-group. Collectively, TG-LASIK induces fewer corneal HOAs even after facilitating between-group comparability using PSM analysis. TG-LASIK provides better visual quality than SMILE for myopia. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

11 pages, 2224 KiB  
Article
Visual Outcomes of Small-Incision Lenticule Extraction (SMILE) in Thin Corneas
by Erika Eskina, Olga Klokova, Roman Damashauskas, Karine Davtyan, Bojan Pajic and Marina Movsesian
J. Clin. Med. 2022, 11(14), 4162; https://doi.org/10.3390/jcm11144162 - 18 Jul 2022
Cited by 3 | Viewed by 2824
Abstract
We aimed to find out whether thin (≤500 μm) or normal (>500 μm, control) corneal thickness would impact efficacy and safety outcomes of small-incision lenticule extraction (SMILE). We retrospectively analyzed medical records of adult patients who had undergone SMILE. A total of 57 [...] Read more.
We aimed to find out whether thin (≤500 μm) or normal (>500 μm, control) corneal thickness would impact efficacy and safety outcomes of small-incision lenticule extraction (SMILE). We retrospectively analyzed medical records of adult patients who had undergone SMILE. A total of 57 eyes were included in the “thin corneas” group and 180 eyes in the “control” group. At one month after surgery, rates of patients with uncorrected distance visual activity (UDVA) ≥ 0.8 were significantly higher in patients from the control group compared to the “thin corneas” group (87 vs. 71%, respectively p < 0.01), though rates were comparable at 3 months (87 vs. 76%, respectively, p > 0.05). SMILE had comparable safety in patients with thin and normal corneas. Procedure result predictability was comparable between groups. Regression analysis demonstrated that cap thickness impacted posterior corneal biomechanics, and the volume of removed tissue had a higher influence in patients with thin corneas. Moreover, an increase in cap thickness was associated with better final BCVA. Further study is needed for the evaluation of the impact of thin corneas on SMILE outcomes and planning. Our study also indicates that patients with thin corneas might require a different approach to nomogram calculation. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

7 pages, 561 KiB  
Article
A New Postoperative Regimen after CXL and PRK Using Topical NSAID and Steroids on the Open Ocular Surface
by Farhad Hafezi, Mark Hillen, Leonard Kollros, Jerry Tan and Shady T. Awwad
J. Clin. Med. 2022, 11(14), 4109; https://doi.org/10.3390/jcm11144109 - 15 Jul 2022
Cited by 6 | Viewed by 2689
Abstract
Corneal epithelium removal during photorefractive keratotomy (PRK), TransPRK, or corneal cross-linking (CXL) means that patients experience pain and inflammation after the procedure, which need to be carefully managed with topical drug regimens. One highly effective class of topical analgesics is non-steroidal anti-inflammatory drugs [...] Read more.
Corneal epithelium removal during photorefractive keratotomy (PRK), TransPRK, or corneal cross-linking (CXL) means that patients experience pain and inflammation after the procedure, which need to be carefully managed with topical drug regimens. One highly effective class of topical analgesics is non-steroidal anti-inflammatory drugs (NSAIDs), but these must be used carefully, as their use has been associated with delayed re-epithelialization and, in rare cases, corneal melting. However, our clinical experience has been that the concomitant use of topical corticosteroids obviates this risk. Here, we present a mechanistic explanation for our observations, our TransPRK and epithelium-off CXL protocols, and the postoperative medication regimens where topical NSAIDs are used in combination with topical steroid therapy during the first two postoperative days (where pain and inflammation levels are the highest). We detail the results of a single-center retrospective case analysis that examined eyes that underwent TransPRK (n = 301) or epithelium-off CXL (n = 576). Topical NSAID use in the first two postoperative days to control pain and inflammation after PRK/TransPRK or epithelium-off CXL, when used in combination with topical steroid therapy, does not appear to be associated with corneal melting or delayed epithelial healing. This approach may represent an improvement over current methods of handling post-surgical pain in procedures that require corneal epithelial debridement. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

Review

Jump to: Research, Other

7 pages, 240 KiB  
Review
Turner Syndrome: Ocular Manifestations and Considerations for Corneal Refractive Surgery
by Majid Moshirfar, Mark T. Parsons, Chap-Kay Lau, Nicholas A. Chartrand, Yasmyne C. Ronquillo and Phillip C. Hoopes
J. Clin. Med. 2022, 11(22), 6853; https://doi.org/10.3390/jcm11226853 - 20 Nov 2022
Cited by 2 | Viewed by 2157
Abstract
Turner Syndrome (TS) is the most common sex chromosome abnormality in females and is associated with physical changes, hormone deficiencies, increased risk of autoimmune disease, and ocular complications. In this article, we review the main ocular findings associated with TS and discuss their [...] Read more.
Turner Syndrome (TS) is the most common sex chromosome abnormality in females and is associated with physical changes, hormone deficiencies, increased risk of autoimmune disease, and ocular complications. In this article, we review the main ocular findings associated with TS and discuss their significance for the patient considering refractive surgery. We also present four cases of TS to highlight the clinical findings that may be present in these patients. The most common ocular manifestations include refractive errors, strabismus, and amblyopia. Less commonly, patients with TS may present with keratoconus, cataracts, glaucoma, uveitis, or other disorders of the posterior segment. When considering corneal refractive surgery in a TS patient, clinicians should perform a thorough ocular history, ask patients about hormone therapy and autoimmune conditions, and pay particular attention to any of the associated ocular symptoms of TS. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
6 pages, 700 KiB  
Review
Corneal Transplant Rejections in Patients Receiving Immune Checkpoint Inhibitors
by Majid Moshirfar, Noor F. Basharat, Tanner S. Seitz, Briana K. Ply, Yasmyne C. Ronquillo and Phillip C. Hoopes
J. Clin. Med. 2022, 11(19), 5647; https://doi.org/10.3390/jcm11195647 - 25 Sep 2022
Cited by 6 | Viewed by 2210
Abstract
Immune checkpoint inhibitors (ICIs) are antibodies that target and block immune checkpoints. These biologics were initially approved by the United States Food and Drug Administration (US FDA) in 2011 for the management of melanoma. Since then, the use of ICI therapy has increased, [...] Read more.
Immune checkpoint inhibitors (ICIs) are antibodies that target and block immune checkpoints. These biologics were initially approved by the United States Food and Drug Administration (US FDA) in 2011 for the management of melanoma. Since then, the use of ICI therapy has increased, with many new medications on the market that treat approximately 50 types of cancers. Patients receiving this therapy are at an increased risk for transplant rejection, including corneal rejection. Ophthalmologists must be aware of individuals receiving ICI therapy as it may be a relative contraindication for patients with a history of corneal transplantation. Patients on ICIs may also experience ocular side effects, including uveitis, dry eye, and inflammation, while on checkpoint inhibitor therapy. This commentary discusses the current understanding of immune checkpoint inhibitors, their mechanism of action, their ocular side effects, and their role in corneal transplant rejection. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

Other

Jump to: Research, Review

12 pages, 2561 KiB  
Case Report
First Clinical Results of a New Generation of Ablative Solid-State Lasers
by Bojan Pajic, Brigitte Pajic-Eggspuehler, Zeljka Cvejic, Christian Rathjen and Viktor Ruff
J. Clin. Med. 2023, 12(2), 731; https://doi.org/10.3390/jcm12020731 - 16 Jan 2023
Cited by 2 | Viewed by 2274
Abstract
In the early 2000s, solid-state lasers emerged as an alternative technology to excimer systems in refractive surgery. Despite some technological limits at the time, good clinical results could be achieved with solid-state laser systems. This prospective case series reports clinical outcomes of five [...] Read more.
In the early 2000s, solid-state lasers emerged as an alternative technology to excimer systems in refractive surgery. Despite some technological limits at the time, good clinical results could be achieved with solid-state laser systems. This prospective case series reports clinical outcomes of five eyes treated with a newly developed solid-state laser system (AquariuZ) in three patients. Patients underwent preoperative examination, including corneal topo-and tomography, aberrometry, and confocal microscopy. All patients received a femtosecond LASIK with the Ziemer LDV Z8, a refractive treatment with the AquariuZ solid-state ablation laser, and were then followed up for a period of up to 12 months. The applied aspheric optimized profiles did not induce higher-order aberrations nor spherical aberration in any of these operated subjects. No eye lost BCVA lines throughout the duration of the follow-up. Six months after surgery, the safety index of patient 1 was 5, and for patients 2 and 3, it equaled 1. Confocal laser microscopy imaging findings were comparable to those seen typically for excimer lasers. The obtained results are encouraging and confirm that the new solid-state laser system is safe. Full article
(This article belongs to the Special Issue Corneal Surgery: From Innovation to Clinical Praxis)
Show Figures

Figure 1

Back to TopTop